Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Feb. 7, 2019. Dirk Westermann.

Executive Summary

New trial results raise some questions about the effectiveness of Abiomed's Impella heart pump. The data underscore the need for randomized studies to help identify the best treatment approach for patients with acute myocardial infarction complicated by cardiogenic shock, trial investigator and cardiologist Dirk Westermann says.

“We don't have a lot of evidence, but we need to run trials as long as we can to find better evidence and then we can treat our patients with more certainty that we're really helping them." – Dirk Westermann, STOP SHOCK trial investigator, University Heart Center (Hamburg, Germany)



Click here for a free trial of Medtech Insight



Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT124607

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel